Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial Meeting Abstract
| Authors: | Ramasamy, K.; Nooka, A.; Cohen, A.; Lee, H.; Badros, A.; Suvannasankha, A.; Callander, N.; Abdallah, A. O.; Trudel, S.; Chari, A.; Libby, E.; Chaudhry, M.; Hultcrantz, M.; Kortüm, K. M.; Richardson, P.; Popat, R.; Sborov, D.; Hakim, S.; Lewis, E.; Bhushan, B.; Gorsh, B.; Gupta, I.; Opalinska, J.; Lonial, S. |
| Abstract Title: | Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial |
| Meeting Title: | 63rd Annual Scientific Meeting of the British Society for Haematology |
| Journal Title: | British Journal of Haematology |
| Volume: | 201 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Apr 23-25 |
| Meeting Location: | Birmingham, United Kingdom |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2023-04-01 |
| Start Page: | 68 |
| End Page: | 69 |
| Language: | English |
| ACCESSION: | WOS:001049283000109 |
| PROVIDER: | wos |
| DOI: | 10.1111/bjh.18720 |
| Notes: | Meeting Abstract: BSH23-PO159 -- Source: Wos |
